Clinical Services Unit
Pharmaceutical Sciences
                                                    Vancouver Acute

[Index]  

CSU-Pharmaceutical Sciences Member Research, Publications, Presentations, Professional and Academic Awards (April 1, 2002 - March 31, 2003 Annual Report)

 

Publications

Presentations

Awards
External  - Refereed & Non-refereed Research Posters/Abstracts Professional Awards
Accepted - in press External Podium Presentations Research Awards
Submitted publications Internal Presentations Grants
Internal publications

 

Published (Refereed, Non-refereed) 

  1. Dossa A. Overcoming barriers to seamless care. Seamless care. A pharmacist's guide to continuous care programs. Canadian Pharmacists Association, March 2003, Chapter 3, pgs. 19-29.
  2. Raymond C. Is there an association between antipsychotics and venous thromboembolism? J Inform Pharmacother 2003;12:300.
  3. Loewen PS, Sprague D. Bedside calculation of stroke risk in patients with atrial fibrillation. Am J Health-Syst Pharm 2003;60:427-429.
  4. Yeung J, Warkentin D. Caspofungin or amphotericin B for invasive candidiasis: caspo-fabulous or ampho-terrific? (article review) J Inform Pharmacother 2003;12:202.
  5. Slavik RS. The atrial fibrillation follow-up investigation of rhythm management: Does this study AFFIRM the need for rate or rhythm control? (article review) J Inform Pharmacother 2003;12:202.
  6. Gorman SK, Zed PJ, Purssell RA, Brubacher J, Willis GA. Antidote stocking in British Columbia hospitals. Can J Emerg Med 2003;5:12-17.
  7. Clark K, Abu-Laban RB, Zed PJ, Graham L. Neurologically normal survival after fibrinolysis during prolonged cardiac arrest: Case report and discussion. Can J Emerg Med 2003;5:49-53.
  8. Gorman SK, Zed PJ, Dhingra V, Ronco J. Rapid imipenem-cilastatin desensitization for multi-drug resistant Acinetobacter baumannii pneumonia. Ann Pharmacother 2003;37:513-516.
  9. Cook T, Frighetto L, Marra C, Jewesson P. Patterns of use and patients' attitudes toward complementary medications: A survey of adult general medicine patients at a major Canadian teaching hospital. Can J Clin Pharmacol 2002:9;183-189.
  10. Jewesson PJ. Direct-to-consumer promotion of prescription drugs: should product manufacturers just stick to toothpaste, trucks and tampons? (editorial) J Inform Pharmacother 2002;10:1.
  11. Bosma TL, Jewesson PJ. An infusion program IV resource nurse consult service: Our experience in a major Canadian teaching hospital. J Intravenous Nurs 2002;25:310-15.
  12. Ensom MH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients. Ther Drug Monit 2002;24:310-314.
  13. Ramji A, Yoshida EM, Bain VG, Kneteman NM, Scudamore CH, Ma MM, Steinbrecher UP, Gutfreund KS, Erb SR, Partovi N, Chung SW, Shapiro J, Wong WW. Late acute rejection after liver transplantation: The Western Canada experience. Liver Transpl 2002;8:945-951.
  14. Esmail Z, Shalansky, KF, Sunderji R, Anton H, Chambers K, Fish W. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: A pilot study. Arch Phys Med Rehabil 2002;83:604-607.
  15. Cherry N, Shalansky KF. Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Health-Sys Pharm 2002;59:1736-1741.
  16. Loewen P. Antiemetics in development. Expert Opin Investig. Drugs 2002;11:801-5.
  17. Loewen P. Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects. Can J Emerg Med 2002;4:268-275.
  18. Loewen P. Nausea & Vomiting. In Repchinsky C, ed. Patient Self Care: Helping patients make therapeutic choices, 1st edition. 2002, Canadian Pharmacists Association, Ottawa, Canada, pgs. 207-220.
  19. Epstein Joel B., Tsang Andrew, Warkentin Dawn, Ship Jonathan A. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:39-44.
  20. Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox V, Ransier A, Barnett MJ, Marra F. A prospective, randomized clinical trial of valacyclovir versus acyclovir in the prevention of mucocutaneous herpes simplex virus infections in neutropenic patients. Ann Pharmacother 2002;36:1525-1531.
  21. Balen RM, Chong E. Maximizing your continuing education yield: Incorporating streaming media into your oral presentations. J Inform Pharmacother 2003;12:500.
  22. Dossa A. Helping Hands: How to assist elderly patients with type 2 diabetes. Pharm Prac 2002;18:33-38.
  23. Balen R. Pharmacy practice: Bringing information to the point of need with hand-held computers. Canadian Pharmacists Association Impact Newsletter 2002;12:6.
  24. Balen RM. How to use email and the internet to help you keep up with the literature (Part I). J Inform Pharmacother 2002;9:500.
  25. Balen RM. How to use email and the internet to help you keep up with the literature (Part II) PubMed and Allied journal club. J Inform Pharmacother 2002;10:500.
  26. Balen RM. How to use email and the internet to help you keep up with the literature (Part III) The therapeutic topic approach and a potential corporate strategy. J Inform Pharmacother 2002;11:500.
  27. Loewen P, Balen R, McCormack J. Redefining and refining the JIP. (editorial) J Inform Pharmacother 2002;9:1.
  28. Mysak T. Perindopril and stroke prevention: are we really making PROGRESS? (article review) J Inform Pharmacother 2002;11:200.
  29. Makowsky M, Mysak T. Can the eradication of Helicobacter pylori reduce the risk of peptic ulcer disease in patients starting NSAIDS? J Inform Pharmacother 2002;10:202.
  30. Druteika D, Zed PJ. Is bupropion cardiotoxic following overdose? Ann Pharmacother 2002;36:1791-1795.
  31. Carr R, Zed PJ. Octreotide in the management of sulfonylurea-induced hypoglycemia following overdose. Ann Pharmacother 2002;36:1726-1732.
  32. Zed PJ, Loewen PS, Jewesson PJ. Pharmacist scope of practice: A Canadian response to the 2002 ACP-ASIM position paper. (commentary) Am J Health Sys Pharm 2002;59:1453-1455.
  33. Yeung JK, Zed PJ. A review of etomidate for rapid sequence intubation in the emergency department. Can J Emerg Med 2002;4:194-198.
  34. Patel P, Zed PJ. Drug-related visits to the emergency department: How big is the problem? Pharmacother 2002;22:915-923.
  35. Ensom MHH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients. Therapeutic Drug Monitor 2002;24:310-314.
  36. Sawoniak AE, Shalansky KF, Zed PJ, Sunderji R. Formulary considerations related to warfarin interchangeability. Can J Hosp Pharm 2002;55:215-218.
  37. Goodfellow AF, Wai AO, Frighetto L, Marra CA, Ferreira BM, Chase ML, Nicol R E, Leong CA, Tomlinson S, Jewesson PJ. Quality of life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002;36:1851-1855.
  38. Slavik RS. Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department. Can J Emerg Med 2002;4:414-420.
  39. Raymond C. Risperiodone or haloperidol for schizophrenic patients: What does a focus on relapse rate reveal? J Inform Pharmacother 2002;9:203.
  40. Slavik RS. Low dose corticosteroids to reduce mortality in patients with septic shock: Selective benefit? (article review) J Inform Pharmacother 2002;11:202.
  41. Pearson G, Yuksel N, Card D, Chin T, Gray M, Hawbold J, Jackevicius C, Slavik RS, Thompson A. Statement on pharmacist prescribing. Can J Hosp Pharm 2002;55:55.
  42. Pearson G, Yuksel N, Card D, Chin T, Gray M, Hawbold J, Jackevicius C, Slavik RS, Thompson A. An information paper on pharmacist prescribing within a health care facility. Can J Hosp Pharm 2002;55:56-62.
  43. Wilbur K. Anti-factor Xa monitoring in overweight and obese patients (letter). Can J Hosp Pharm 2002;5:336-337.

 

Accepted (Refereed, Non-refereed)

  1. Bosma L, Balen RM, Davidson E, Jewesson P. Point of Care Use of a Personal Digital Assistant for Patient Consult Management: Experience of an Intravenous Resource Nurse team in a Major Canadian Teaching Hospital. CIN 2003 (refereed, accepted).
  2. Gorman SK. Epo for critically ill patients: does it reduce transfusion requirements? J Inform Pharmacother 2003 (refereed, accepted).
  3. Yeung J, Warkentin D. Caspofungin or amphotericin B for invasive xandidiasis: Caspo-fabulous or ampho-terrific? J Inform Pharmacother 2003 (refereed, accepted).
  4. Loewen P. Evidence-based Pharmacotherapy: A practical guide for pharmacists. Virtual Learning, Inc. 2003 (refereed, accepted).
  5. Zed PJ, Loewen PS, Abu-Laban R, Rowe B. Appraisal of systematic reviews by emergency physicians. Can J Emerg Med 2003 (refereed, accepted).
  6. Loewen P, Lamb S, Clugston P. A randomized, double-blind, trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Ann Plast Surg 2003 (refereed, accepted).
  7. Sprague D, Loewen PS, Raymond C. Selection criteria for atypical antipsychotics in schizophrenia. Ann Pharmacother 2003 (refereed, accepted).
  8. Conneally E., Warkentin DI, Earl L. eds. BMT/Leukemia Pocket Manual. Fourth Edition, April 2003, in press.
  9. Leung VWY, Sunderji R, Zed PJ, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: A local analysis (SWAP Study). Can J Cardiol 2003 (refereed, accepted).
  10. Sunderji R, Fung A, Gin K, Shalansky K, Carter C. Self-management of warfarin: A Review. Can J Cardiol 2003 (refereed, accepted).
  11. Slavik R, Jewesson P. Selecting antibacterials for outpatient parenteral antimicrobial therapy (OPAT): Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 2002 (refereed, accepted).

 

Submitted (Refereed, Non-refereed)

 

 Internal Publications

  1. Carr R, Shalansky KF, Sunderji R. Cardiovascular effects of COX-2 inhibitors. Drug and Therapeutics Newsletter 2003:10(1):3-5.
  2. Raymond C. Quetiapine (Seroquelâ). Drug and Therapeutics Newsletter 2002:9(3):3,4.
  3. Lacaria K, Raymond C. Zuclopenthixol acetate injection (Clopixol Acuphaseâ). Drug and Therapeutics Newsletter 2002:9(3);4,5.
  4. Druteika D, Sunderji R, Zed P, Loewen P. Reteplase (r-PA). Drug and Therapeutics Newsletter 2002:9(3);6-8.
  5. Shalansky K, Benny B. Iron sucrose (Venoferâ): Serious adverse events at VH. Drug and Therapeutics Newsletter 2002:9(3);8.
  6. Greanya E, Shalansky K, Mysak T. Tizanidine (Zanaflexâ). Drug and Therapeutics Newsletter 2002:9(3);3,4.
  7. Raymond C. Mirtazapine (Remeronâ). Drug and Therapeutics Newsletter 2002:9(3);4-6.
  8. Lacaria, Balen RM, Frighetto L, Lau TTY, Naumann TL, Jewesson PJ. Perceptions of Pharmaceutical Sciences Services at VGH: Survey results. Drug and Therapeutics Newsletter 2002;9(4):6,7.
  9. Lau T. Itraconazole oral (Sporanoxâ). Drug and Therapeutics Newsletter 2002;9(2):3,4.
  10. Naumann T. Valacyclovir oral (Valtrexâ). Drug and Therapeutics Newsletter 2002;9(2):4,5.
  11. Carr R, Lau T, Shalansky K. Clarithromycin (Biaxinâ). Drug and Therapeutics Newsletter 2002;9(2):6,7.
  12. E MI. Estradotâ patch (Transdermal Estrogen). Drug and Therapeutics Newsletter 2002:9(2):7,8.

The Drug and Therapeutics Newsletter is produced by Clinical Service Unit Pharmaceutical Sciences (Vancouver Acute), Vancouver Coastal Health Authority and is distributed to approximately 270 external subscribers and 1,171 copies are distributed internally every 3 months. The newsletter is also available for review on our website at www.vhpharmsci.com. The editorial board for this publication is Karen Shalansky, Peter Loewen, Rubina Sunderji, Luciana Frighetto and Peter Jewesson.

 

Research Posters/Abstracts

  1. Partovi N, Ensom MHH, Fradet G, Ignaszewski AP, Levy RD. Factors influencing mycophenolate mofetil drug exposure in thoracic organ transplant recipients. Canadian Society of Transplantation, Annual Scientific Meeting, Lake Louise, AB, March 2003.
  2. Shapiro RJ, Marra C, Ross P, Landsberg D, Keown P, Partovi N. Immunosuppression as a determination of renal function in renal transplant recipients. Canadian Society of Transplantation, Annual Scientific Meeting, Lake Louise, AB, March 2003.
  3. Wai AO, Balen RM, Jewesson P. Point of care use of a Personal Digital Assistant (PDA) for patient consult management in an Outpatient Parenteral Antibiotic Therapy (OPAT) program: Pharmacist experience in a major Canadian teaching hospital. (poster - encore) Western Branches Canadian Society of Hospital Pharmacists 29th Annual Banff Seminar, Banff, AB, March 2003.
  4. Chong E, Balen RM. Facilitating delivery of continuing pharmacy education via streaming media in a large Canadian tertiary care teaching hospital. (poster-encore) Western Branches Canadian Society of Hospital Pharmacists 29th Annual Banff Seminar, Banff, AB, March 2003. (Awarded 1st Place Prize for Best Poster).
  5. Leung VWY, Sunderji R, Zed Peter J, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP Study). Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  6. Sunderji R, Gin K. Assessment of patients' knowledge for warfarin: Identifying gaps and need for improved patient education. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  7. Lacaria K, Balen RM, Frighetto L, Lau TTY, Naumann TL, Jewesson PJ. Perceptions of professional services of a pharmacy department: A comparison of stakeholder groups. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. Can J Hosp Pharm 2003;56 Suppl 1:S65. (Published in J Inform Pharmacother 2002;11:408).
  8. Wai AO, Balen RM, Jewesson P. Point of care use of a Personal Digital Assistant (PDA) for patient consult management in an Outpatient Parenteral Antibiotic Therapy (OPAT) program: Pharmacist experience in a major Canadian teaching hospital. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. Can J Hosp Pharm 2003;56 Suppl 1:S53.
  9. Cecillon DL, Balen RM. A comparison of Personal Digital Assistant (PDA) database software: A guide to choosing an application for professional practice data management. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in Can J Hosp Pharm 2003;56 Suppl 1:S53).
  10. Loewen P, Balen RM. Making Vancouver Hospital's Parenteral Drug Therapy Manual available on a Personal Digital Assistant (PDA). Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in Can J Hosp Pharm 2003;56 Suppl 1:S54).
  11. Loewen P. Development of "Bedside EBM": A handheld tool for storing, retrieving, and applying clinical trial data at the point-of care. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  12. Loewen P, Balen RM. Making Vancouver Hospital's Formulary handbook available on a Personal Digital Assistant (PDA). Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in Can J Hosp Pharm 2003;56 Suppl 1:S55).
  13. Loewen P, Sprague D. A handheld tool for estimating individualized risk of stroke and serious bleeding with warfarin or aspirin in atrial fibrillation patients. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  14. Hussaini T, Partovi N, Shapiro RJ. Evaluation of cardiac risk factors in renal transplant recipients. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in J Inform Pharmacother 2002;11:411).
  15. Buchkowsky S, Jewesson PJ. An assessment of the affiliation between authors and sponsors of published clinical trials over a 20-year period: An unhealthy alliance? Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  16. Balen RM, Jewesson PJ. Pharmacist computer skills and needs assessment survey. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in Can J Hosp Pharm 2003;56 Supp 1:S64).
  17. Chong E, Balen RM. Facilitating delivery of continuing pharmacy education via streaming media in a large Canadian tertiary care teaching hospital. Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in Can J Hosp Pharm 2003;56 Suppl 1:S64).
  18. Slavik, RS. New strategies for glucose control in the acutely ill patient: Focus on insulin infusions. American Society of Hospital (ASHP) 37th Pharmacists Midyear Clinical Meeting, December 2002, vol. 37, pp. PI-43 retrieved from International Pharmaceutical Abstracts.
  19. Slavik RS. Moving towards euglycemia in the acutely ill: A review of the evidence. American Society of Hospital Pharmacists (ASHP) 37th Midyear Clinical Meeting, Atlanta, GA, December 2002. Vol. 37, pp. PI-41 retrieved from International Pharmaceutical Abstracts.
  20. Gorman SK, Zed PJ, Purssell RA, Brubacher J. Antidote available in British Columbia hospitals. Canadian Society of Hospital Pharmacy (BC Branch) Annual General Meeting, Vancouver, BC, November 2002.
  21. Shalansky K. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. ACCP Annual General Meeting Poster Presentation, Albuquerque, NM, October 2002.
  22. Shalansky K. Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients. ACCP Annual General Meeting Poster Presentation, Albuquerque, NM, October 2002.
  23. Balen R, Jewesson P. Pharmacist computer skills and needs assessment survey (Poster #90) 5th annual meeting, Canadian Society of TeleHealth, e-Health care: What constitutes return on investment, Vancouver, BC, October, 2002.
  24. Ensom MHH, Partovi N, Kwan L, Decarie D, Ignaszewski AP, Fradet G, Levy RD. Pharmacokinetics of mycophenolate in the early period following lung and heart transplantation. Pharmacotherapy 2002:22:1371 (#303) (Abstract). ACCP Annual Meeting, Albuquerque, NM, October 2002.
  25. Davidson E, Bosma L, Balen R, Jewesson P. Point of care use of a personal digital assistant (PDA) for patient consult management: Experience of an intravenous resource nurse team in a major Canadian teaching hospital. CINA (Canadian Intravenous Nurses Association) Conference 2002, North York, ON, October 2002. www.cina.ca (Awarded 3rd place Research Poster Prize).
  26. Leung V, Sunderji R, Zed PJ, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP study). Canadian Society of Hospital Pharmacy Annual General Meeting, Vancouver, BC, August 2002. (Published in J Inform Pharmacother 2002;11:412).
  27. Curran R, Dossa A, Wilbur K. Characterizing patient discharge counseling activities performed by hospital pharmacists. Canadian Society of Hospital Pharmacists Annual General Meeting, Vancouver, BC, August 2002. (Published in J Inform Pharmacother 2002;11:409).
  28. Curran R, Dossa A, Wilbur K. Characterizing patient discharge counseling activities performed by hospital pharmacists. Canadian Society of Hospital Pharmacists (BC Branch) Residency Presentation Night, Vancouver, BC, May 2002.
  29. Leung V, Sunderji R, Zed PJ, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP study). Canadian Society of Hospital Pharmacists (BC Branch) Residency Presentation Night, Vancouver, BC, May 2002.
  30. Esmail Z, Shalansky K, Sunderji R, Anton H, Chambers K, Fish B. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: A pilot study. Canadian Society of Hospital Pharmacists (BC Branch) Residency Presentation Night 2002, Vancouver, BC, May 2002.
  31. Esmail Z, Shalansky K, Sunderji R, Anton H, Chambers K, Fish B. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: A pilot study. AISA/IMSOP Poster Presentation, Vancouver, BC, May 2002. (Awarded Best Research Poster).
  32. Partovi N, Keown P, Shapiro RJ. Therapeutic drug monitoring for tacrolimus in kidney and kidney-pancreas transplant recipients. (Abstract#1040), American Transplant Congress, Washington, DC, May 2002. (Published in American Journal Transplantation 2002;2(S3):400.
  33. Landsberg D, Keown P, Ross P, Partovi N, Shapiro R. Long term follow up of conversion from mycophenolate (MMF) to azathioprine (AZA) in stable renal transplant patients. (Abstract #397), American Transplant Congress, Washington, DC, May 2002. (Published in American Journal Transplantation 2002);2(S3):237.
  34. Levy RD, Partovi N, Decarie D, Dumont RJ, Fradet G, Keown P, Ensom MHH. Pharmacological characteristics of mycophenolate mofetil in stable lung transplant recipients. American Thoracic Society 2002, Atlanta, GA, May 2002.
  35. Lacaria K, Balen RM, Frighetto L, Lau TTY, Naumann TL, Jewesson PJ. An evaluation of Pharmaceutical Sciences Clinical Service Unit professional services in a major teaching hospital: A comparison of stakeholder perceptions. Canadian Society of Hospital Pharmacists (BC Branch) Residency Presentation Night, Vancouver, BC, May 2002.
  36. Sprague D, Loewen P, Wilbur K. Feasibility of implementing an individualized, evidence-based stroke prevention counselling program for patients with atrial fibrillation. Canadian Society of Hospital Pharmacists (BC Branch) Residency Presentation Night 2002, Vancouver, BC, May 2002. (Published in J Inform Pharmacother 2002;11:402).
  37. Ip J, Cadieu T, McKnights D, Abu-Laban, RB, Zed PJ. Institutional variation in emergency department management of atrial fibrillation: A comparison of two Canadian centres. Canadian Association of Emergency Physicians (CAEP) Annual Scientific Meeting, Hamilton, ON, April 2002.
  38. Ip J, Sandhu M, McKnight D, Abu-Laban RB, Zed PJ. A survey of emergency physicians' attitudes towards primary electrical cardioversion for stable paroxysmal atrial fibrillation of less than 48 hours duration. Canadian Association of Emergency Physicians (CAEP) Annual Scientific Meeting, Hamilton, ON, April 2002.
  39. Gorman SK, Zed PJ, Purssell RA, Brubacher J. Antidote availability in British Columbia hospitals. Canadian Association of Emergency Physicians (CAEP) Annual Scientific Meeting, Hamilton, ON, April 2002.

 

External Podium Presentations

  1. Sunderji R. "Cardiovascular drugs in the elderly". Gerentology Session. Simon Fraser University, Burnaby, BC, March 2003.
  2. Balen R. "Personal Digital Assistants (PDAs) in pharmacy practice: Basics and beyond". Richmond General Hospital Pharmacy Rounds. Richmond General Hospital, Richmond, BC, March 2003.
  3. Balen R. "Personal Data Assistants (PDAs) in Pharmacy Practice: Basics and beyond". Western Branches Canadian Society of Hospital Pharmacists 29th Annual Banff Seminar, Banff, AB, March 2003.
  4. Slavik R. "Controversies in atrial fibrillation: Does the rhythm method really work?". Vancouver Coastal Health Authority - Nursing Cardiac Education Day, Vancouver, BC, March 2003.
  5. Lau TTY. "Antibiotics I: Structure and function & Antibiotics II: Clinical application". Pathology 327 Medical Microbiology Course, Department of Pathology & Laboratory Medicine, Faculty of Medicine, UBC. (repeated at 2 sessions - February 2003).
  6. Mysak T. "Moving ahead in Parkinson's". Continuing Education, Update 2003 - Vancouver, BC, February 2003.
  7. Dossa, A. "Diabetes and the older adult". Gerontology 402-Drug Issues in Gerontology. Simon Fraser University, Vancouver, BC, February 2003.
  8. Sunderji R. "Practical implications of using glycoprotein IIB/IIIA inhibitors". Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  9. Slavik R. "Antimicrobial pharmacodynamics: Just all smoke and mirrors?" Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  10. Dar Santos A, Shalansky K, and Jastrzebski J. "Multidisciplinary approach to erythropoietin resistance in a hemodialysis unit". Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003. (Published in J Inform Pharmacother 2002;11:413).
  11. Loewen PS. "Literature searching skills". BC Hospital Pharmacy Residents, Vancouver, BC, February 2003.
  12. Chong E, Balen RM. "Facilitating delivery of continuing pharmacy education via streaming media in a large Canadian tertiary care teaching hospital". Canadian Society of Hospital Pharmacists (CSHP) 34th Professional Practice Conference, Toronto, ON, February 2003.
  13. Jewesson PJ. "Behind the scenes of drug research, publication and promotion: We're not in Kansas anymore, Toto…". 12th Annual Invitation Management and Clinical Seminar for Pharmacy Managers, Harrison Conference 2000, Harrison Hot Springs, BC, February 2003.
  14. Partovi N. "Therapeutic drug monitoring for mycophenolate mofetil". Transplant meeting, Toronto, ON, January 2003.
  15. Loewen PS. "Ethical review case study". National Council on Ethics in Human Research Workshop, Vancouver, BC, January 2003.
  16. Shapiro RJ, Marra CA, Ross P, Landsberg D, Keown PA, Partovi N. "Immunosuppression as a determinant of renal function in renal transplant recipients". BC Transplant Research Day, Vancouver, BC, December 2002.
  17. Partovi N, Ensom MHH, Ignaszewski AP, Fradet G, Levy RD. "Factors influencing mycophenolate mofetil drug exposure in thoracic organ transplant recipients". Annual Transplantation Research Day, Vancouver, BC, December 2002.
  18. Warkentin D. "New drug therapies-focus on voriconazole, caspofungin, and imatinib". Leukemia/BMT Program of BC Interdisciplinary Education Session, Plaza 500 Hotel, Vancouver, BC, November 2002. (repeated at 2 sessions - November-December 2002).
  19. Partovi N. "New immunosuppressive medications for solid organ transplant recipients". Regional transplant nurses education day, British Columbia Transplant Society, Vancouver, BC, November 2002.
  20. Partovi N. "Research workshop". Annual meeting of BC Canadian Society of Hospital Pharmacists, Vancouver, BC, November 2002.
  21. Balen, R. "Top ten ways to keep up with the literature". Canadian Society of Hospital Pharmacists (BC Branch) Annual General Meeting, Vancouver, BC, November 2002.
  22. Sunderji R. "Cardiology update - Translating clinical trial results into practice". Canadian Society of Hospital Pharmacists (BC Branch) Annual General Meeting, Vancouver, BC, November 2002.
  23. Sunderji R. "Use of antithrombotics in cardiovascular disease". British Columbia Pharmacists Association Continuing Education Event, Richmond, BC, November 2002.
  24. Raymond, C. "Atypical antipsychotics - practical tips to compare agents". Canadian Society for Hospital Pharmacists (BC Branch) Annual General Meeting, Vancouver, BC, November 2002.
  25. Zed PJ. "Pharmacist managed anticoagulation: Emergency department perspectives" Canadian Society of Hospital Pharmacists (BC Branch) Annual General Meeting, Vancouver, BC, November 2002.
  26. Zed PJ. "Clarifying the confusion of acute coronary syndromes: What does the evidence tell us?" Pharmacology Rounds, Royal Columbian Hospital, New Westminster, BC, November 2002.
  27. Dossa A. "Diabetes management trends". BCPhA all day continuing education event, Vancouver Airport Marriott, Coastal Mountain Ballroom, Richmond, BC, November 2002.
  28. Warkentin D. "Update on antifungal agents". Canadian Society of Hospital Pharmacists (BC Branch) Annual General Meeting, Hyatt Hotel, Vancouver, BC, November 2002.
  29. Shalansky K. "Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients". CANNT/RPN Conference, Toronto, ON, November 2002.
  30. Zed PJ. "Antibiotics….handle with care!" University of British Columbia Continuing Pharmacy Education Program, Abbotsford, BC. (repeated at 3 sessions - October 2002).
  31. Warkentin D. "Review of immunosuppressive agents used in severe aplastic anemia and myelodysplastic syndrome". BC Chapter of the Aplastic Anemia and Myelodysplasia Association of Canada, Canadian Blood Services, Vancouver, BC, October 2002.
  32. Dossa A. "The community pharmacist's role in diabetes management". BCPhA Conference, Delta Ocean Pointe Resort Hotel, Victoria, BC, October 2002.
  33. Slavik RS. "So you think your patient needs a motility agent?" Nestle Nutrition Conference, British Columbia Dieticians Association Conference, Vancouver, BC, October 2002.
  34. Slavik RS. "Using systematic reviews for D&T decision-making", Federal Pharmacy and Therapeutics Committee Meeting (Health Canada), St. John's, Newfoundland, September 2002.
  35. Raymond, C. "Alzheimer's, new hope or old hype?" Canadian Society for Hospital Pharmacists Fraser Valley Chapter CE Event, September 2002.
  36. Loewen P. "Critically evaluating clinical trials". Fraser Valley Internists' Society Annual Meeting, Whistler, BC, September 2002.
  37. Slavik RS. "Pharmacotherapy of sepsis: Past, present, and future". Simon Fraser Health Region Pharmacology Rounds, Royal Columbian Hospital, August 2002.
  38. Loewen P. "Clinical pharmacist as information manager: Accessing the evidence where and when you need it". Canadian Society of Hospital Pharmacists Annual General Meeting, Vancouver, BC, August 2002.
  39. Zed PJ. "Clinical practice guidelines workshop". Canadian Society of Hospital Pharmacists Annual General Meeting, Vancouver, BC. (repeated at 2 sessions - August 2002).
  40. Jewesson PJ. "Pharmacists and potential conflicts of interest - Doing the right thing". Canadian Society of Hospital Pharmacists Annual General Meeting, Vancouver, BC, August 2002. (Published in J Inform Pharmacother 2002;11:1).
  41. Slavik RS. "Retrieving and appraising systematic reviews". Canadian Society of Hospital Pharmacists Annual General Meeting, Vancouver, BC, August 2002.
  42. Zed PJ. "Acute pain management of the trauma patient in the emergency department". University of British Columbia Telehealth Continuing Medical Education Program, Terrace/Cranbrook, BC, June 2002.
  43. Raymond C. "The difficulty of dementia". New Ideas for Old Friends Conference, UBC Continuing Pharmacy Education, Vancouver, BC, June 2002.
  44. Loewen P. "Ethical issues for investigators in industry sponsorship of anaesthesiology research". Presented to Anaesthesiologists at Canadian Anaesthesiologists Society 58th Annual Congress, Victoria, BC, June 2002.
  45. Zed PJ. "Acute pain management of the trauma patient". University of British Columbia Telehealth Continuing Medical Education Program, Terrace/Cranbrook, BC, May 2002.
  46. 46. Zed PJ. "Clarifying the confusion of acute coronary syndromes: What does the evidence tell us?" Canadian Society of Hospital Pharmacists (BC Branch) Northern Chapter, Prince George, BC, May 2002.
  47. Slavik RS. "Pharmacotherapy of sepsis: Past, present, and future". Canadian Society of Hospital Pharmacists (BC Branch) Northern Chapter Event, Prince George Regional Hospital, Prince George, BC, May 2002.
  48. Warkentin D. "A prospective, randomized clinical trial of valacyclovir vs. acyclovir in the Prevention of mucocutaneous herpes simplex virus infections in neutropenic patients" platform presentation. Canadian Bone Marrow Transplant Group Meeting, 8th Conference, Halifax, NS, May 2002.
  49. Loewen P. "Secret remedies of drug-induced adverse effects". Presented to physicians and pharmacists at the Therapeutics Initiative's 13th Annual Drug Therapy Decision Making Course, Richmond, BC, May 2002.
  50. Zed, PJ, "Emergency drugs: STAT versus stats". Therapeutics Initiative 13th Annual Drug Therapy Decision Making Course, Richmond, BC, May 2002.
  51. Loewen P. "Therapeutic substitution: The good, the bad, and the ugly". Presented to W.H. Mercer Inc. staff. Vancouver, BC, May 2002.
  52. Loewen P. "Advantages, disadvantages and insights into drug formularies". Presented to W.H. Mercer Inc. staff. Vancouver, BC, April 2002.
  53. Loewen P. "Primary and secondary prevention of stroke: Navigating the evidence and making excellent decisions". Canadian Society of Hospital Pharmacists (BC Branch) Spring Therapeutics Update, Burnaby, BC, April 2002.
  54. Zed PJ. "Acute pain management of the trauma patient in the emergency department". MSA Hospital Pain Management Conference, MSA General Hospital, Abbotsford, BC, April 2002.

 

Internal Presentations

  1. Dossa A. "ABC's of diabetes". Outpatient Diabetes Clinic. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 42 sessions - April 2002-March 2003).
  2. Partovi N. "The role of immunosuppressive agents in solid organ transplantation". Transplant Education day, Solid organ transplant unit, Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 4 sessions - May 2002-March 2003).
  3. Partovi N. "Pharmacokinetic drug monitoring of immunosuppressive agents". Transplant review rounds, Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 4 sessions - May 2002-March 2003).
  4. Warkentin D. "Supportive care agents in stem cell transplantation". E6 Nursing Orientation. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 6 sessions - April 2002-March 2003).
  5. Sunderji R. "Medications for the heart". Presentations to clients enrolled in the Healthy Heart Program (repeated at 11 sessions - April 2002-January 2003).
  6. Wilbur K. "Improving quality of medication use in the elderly - A not-so simple prescription". Geriatric Medicine Division Rounds, Vancouver Coastal Health Authority, VGH Site. (repeated at 2 sessions - January-April 2003).
  7. Sunderji R. "Reteplase for myocardial infarction". CCU Nursing inservices, (repeated at 2 sessions - January-February 2003).
  8. Dossa A. "Knowledge is the best medicine". Patient Education Day, Renal Clinic, Echelon Building, Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 2 sessions - October 2002-March 2003).
  9. Mysak T. "Antithrombotic therapy". Neurosciences nursing orientation. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 6 sessions - September 2002-March 2003).
  10. Dossa A. "Oral agents used to treat type 2 diabetes". Inservice to Renal Unit. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 5 sessions - August-November 2002).
  11. Raymond C. "Medications in psychiatry" orientation for psychiatry nursing students. Vancouver Hospital and Health Sciences Centre, UBC site. (repeated at 6 sessions - June-November 2002).
  12. Shalansky K. "Hypertension management" - Renal Unit Nursing Inservices x 30 minutes. (repeated at 4 sessions - July-October 2002).
  13. Raymond C. "Antipsychotic review" orientation for medical students and psychiatry residents. Vancouver Hospital and Health Sciences Centre, UBC Site. (repeated at 3 sessions - July-October 2002).
  14. Zed PJ. "Acute pain management and conscious sedation" Emergency Department Nursing Orientation. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 2 sessions - April-September 2002).
  15. Zed PJ. "Rapid sequence intubation" Emergency Department Nursing Orientation. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 2 sessions - April-September 2002).
  16. Shalansky K. "Anemia/Osteodystrophy management" - Renal Unit Nursing Inservices x 30 minutes. Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 4 sessions - June 2002).
  17. Raymond C. "Atypical antipsychotics - practical tips to compare agents". Psychiatry Continuing Education Rounds. Vancouver Hospital and Health Sciences Centre, UBC site. (repeated at 4 sessions - May-June 2002).
  18. Loewen P. "Eptifibatide". Inservice education to Clinical Teaching Unit nurses at UBCH, Vancouver Hospital and Health Sciences Centre, UBCH Site. (repeated at 8 sessions - March-April 2002).
  19. Zed PJ. "Pharmacist managed anticoagulation: Emergency department perspectives" CSU Pharmaceutical Sciences, Vancouver Hospital and Health Sciences Centre, VGH Site, Vancouver, BC, March 2003.
  20. Gorman S. "Potassium homeostasis and therapeutics". VGH Pharmacy Resident Presentation, Vancouver Hospital and Health Sciences Centre, VGH Site, March 2003.
  21. Slavik, R. "Applied pharmacokinetics and pharmacodynamics of antimicrobial agents in the critically-ill", VGH/SPH ICU Fellows Didactic Session, Vancouver Hospital and Health Sciences Centre, VGH Site, February 2003. Gorman S. "Corticosteroid use in the intensive care unit. What are the nursing implications?" Vancouver Hospital and Health Sciences Centre, VGH Site, ICU-2 Nursing, January 2003.
  22. Slavik R. "Shocking new treatments for the pharmacotherapy of sepsis…in the ED -steroids, vasopressin, and a critical look at APC", Department of Emergency Medicine Pharmacology Rounds, Vancouver Hospital and Health Sciences Centre, VGH Site, January 2003.
  23. Mysak T. "Pain management". Dialysis Unit nursing in-service. Vancouver Hospital and Health Sciences Centre. VGH Site, January 2003.
  24. Raymond C. "Is there a new truth serum? What are we going to do without sodium amytal? University of British Columbia Neuropsychiatry Rounds. Vancouver Hospital and Health Sciences Centre, UBC site, December, 2002.
  25. Shalansky K. "Dialysis of drugs" - Renal Unit Nursing Inservices x 30 minutes. Vancouver Hospital and Health Sciences Centre, VGH Site (repeated at 3 sessions - November 2002).
  26. Dossa A. "Oral agents used to treat Type 2 diabetes". Renal Program Rounds. Vancouver Hospital and Health Sciences Centre, VGH Site, November 2002.
  27. Loewen P. "Reteplase: A new thrombolytic in acute coronary syndromes". Inservice education to Emergency Department nurses at UBCH, Vancouver Hospital and Health Sciences Centre, UBCH Site, November 2002.
  28. Raymond C. "Treatment of acute psychosis in the emergency department". Vancouver Hospital Emergency Department Pharmacology Rounds. Vancouver Hospital and Health Sciences Centre, UBC site, November 2002.
  29. Zed PJ. "The VGH outpatient DVT treatment program: Clinical outcomes, economic evaluation and patient satisfaction" Research Rounds, Department of Emergency Medicine, Vancouver Hospital and Health Sciences Centre, VGH Site, November 2002.
  30. Zed PJ. "Clarifying the confusion of acute coronary syndromes: What does the evidence tell us? Pharmacology Rounds, Department of Emergency Medicine, Vancouver Hospital and Health Sciences Centre, VGH Site, October 2002.
  31. Dossa A. "Overview of Type 2 diabetes". Pharmaceutical Sciences CSU. Vancouver Hospital and Health Sciences Centre, VGH Site, October 2002.
  32. Sunderji R. "Basic pharmacology principles of select cardiovascular drugs". Cardiology Pharmacology Rounds, Division of Cardiology, Vancouver General Hospital and St. Paul's Hospital, Vancouver, BC, September 2002. Slavik RS. "Retrieving and appraising systematic reviews", Pharmacy Rounds, CSU Pharmaceutical Sciences, Vancouver Hospital and Health Sciences Centre, VGH Site. (repeated at 2 sessions - September 2002).
  33. Warkentin D. "Disseminated fusarial infections in immunocompromised hosts". Bone Marrow Transplantation Seminar, Vancouver Hospital and Health Sciences Centre, VGH Site, September 2002.
  34. Zed PJ. "Pharmacotherapy issues in the emergency medicine: STAT vs. stats!" Pharmacology Rounds, Department of Emergency Medicine, Vancouver Hospital and Health Sciences Centre, VGH Site, September 2002.
  35. Mysak T. "ASPECT-2" Journal Club. CSU Pharmaceutical Sciences, Vancouver Hospital and Health Sciences Centre, VGH Site, September 2002.
  36. Warkentin D. "A novel amphotericin B prescribing protocol". Bone Marrow Transplantation Seminar, Vancouver Hospital and Health Sciences Centre, VGH Site, August 2002.
  37. Slavik RS. "Pharmacotherapy of sepsis: Past, present, and future". UBC Department of Surgery, Faculty of Medicine, Trauma Services Rounds, Vancouver Hospital and Health Sciences Centre, VGH Site, July 2002.
  38. Slavik RS. "Bugs and drugs: Antimicrobial use in the ICU", UBC Division of Continuing Education, Faculty of Medicine,Telehealth Session, Vancouver Hospital and Health Sciences Centre, VGH Site, July 2002.
  39. Slavik RS. "New approaches to the pharmacotherapy of sepsis", UBC Division of Continuing Education, Faculty of Medicine,Telehealth Session, Vancouver Hospital and Health Sciences Centre, VGH Site, July 2002.
  40. Shalansky K. "Drugs and dialysis" - Renal Unit Technicians x 1 hour. Vancouver Hospital and Health Sciences Centre, VGH Site, June 2002.
  41. Balen, R. "PDAs in pharmacy practice: Frequently asked questions". Pharmacy Rounds, Vancouver Hospital and Health Sciences Centre, VGH Site, Vancouver, BC, June 2002.
  42. Slavik RS. "Management of supraventricular arrhythmias", UBC Division of Continuing Education, Faculty of Medicine,Telehealth Session, Vancouver Hospital and Health Sciences Centre, VGH Site, May 2002.
  43. Slavik RS. "Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized, controlled trial". CSU Pharmaceutical Journal Club, Vancouver Hospital and Health Sciences Centre, VGH Site, April 2002.
  44. Slavik RS. "Clinical application of intrope and vasopressor use in the ICU." VGH Critical Care Medical Resident Teaching Series, Vancouver Hospital and Health Sciences Centre, VGH Site, April 2002.

 

Professional Awards

  1. Balen, R. 2003 Best Poster Award, Western Branches Canadian Society of Hospital Pharmacists 29th Annual Banff Seminar.
  2. Slavik, R. 2002 Canadian Society of Hospital Pharmacists BC Branch - Past President Award.
  3. Sunderji R. The BC College of Pharmacists Certificate of Merit Award in recognition of service to the profession of pharmacy, November 2002.

 

Research Awards

  1. Leung VWY, Sunderji R, Zed PJ, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP Study). Canadian Society of Hospital Pharmacists/Merck Frosst Award for Rationale Drug Use National Research Award, February 2003.
  2. Shalansky K. CSHP/Roche & Pharmacia Award (Specialty Practice). For: Dar Santos A, Shalansky KF, Jastrzebski J. Multidisciplinary approach to erythropoietin resistance in a hemodialysis unit, February 2003.
  3. Balen, R. Management issues in pharmaceutical care. Canadian Society of Hospital Pharmacists Apotex National Research Award, February 2003.
  4. Esmail Z, Shalansky K, Sunderji R, Anton A, Chambers K, Fish W. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. Canadian Society of Hospital Pharmacists BC Branch Publication Award in recognition of outstanding contribution to the pharmacy literature, November 2002.
  5. Shalansky K. Third best poster - U.S. $150.00 at AISA/ISOP Poster Presentation "Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study". Vancouver, BC, May 2002

 

Grants

  1. Dr. J. de Lemos (CSU Pharm Sciences, VHHSC) and her co-investigator Dr. D. Chittock (Critical Care-ICU Administration) received the BC Medical Services foundation grant for study proposal "Does early detection and treatment of delirium shorten duration of mechanical ventilation: A Randomized controlled trial" for the amount of $31,900 in March 2003.
  2. Dr. R. Sunderji received a Grant in Aid awarded by the Heart and Stroke Foundation of BC and Yukon in the amount of $25,475.00 in June 2002.
  3. Dr. D. Warkentin received the Interdisciplinary Research Grant for the pilot study entitled "Cyclosporine Pharmacokinetic Monitoring in Allogeneic Bone Marrow Transplantation Patients" for the amount of $10,000 in April 2002.
  4. Dr. K. Wilbur (CSU Pharm Sciences, VHHSC) and her co-investigators Dr. RYM Wong (Geriatric Medicine), Dr. D. Chittock (Critical Care-ICU Administration) et al. received the Phyllis Howard Endowment Fund research grant for study proposal "Clinical outcomes of elderly patients in an Acute Care for Elders (ACE) unit: An inter-disciplinary controlled study" for the amount of $20,000 in March 2002.

[Home] [Top]